ArticleEuropean heart journal open2024

Drug-target Mendelian randomization analysis supports lowering plasma ANGPTL3, ANGPTL4, and APOC3 levels as strategies for reducing cardiovascular disease risk.

Fredrik Landfors et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.